INNOHEP Solution for Injection
Tinzaparin sodium
10000 IU/ml
AIN MEDICARE SDN. BHD
| Pack size | 10 Pre-filled Syringe (0.35 ml) |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 13.79 AED |
Available as:
Indications
INNOHEP Solution for Injection is used for:
Tinzaparin is used for the prevention of postoperative venous thromboembolism in patients undergoing orthopedic surgery and in patients undergoing general surgery who are at high risk of developing postoperative venous thromboembolism. It is also used for the treatment of deep vein thrombosis and/or pulmonary embolism. It is indicated for use in preventing clot formation in indwelling intravenous lines for hemodialysis
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Tinzaparin sodium :
Mechanism of Action
Tinzaparin binds to the plasma protein antithrombin III, forming a complex with then accelerates the inhibition of factor Xa. Its affinity for factor Xa is 2-4 times greater than that of unbound ATIII. The inactivation of factor Xa in turn will exponentially generation of thrombin (factor IIa) molecules, which is needed to activate fibrinogen to fibrin. The coagulation cascade is inhibited because fibrin cannot be formed in the presence of tinzaparin. Like all LMWH, it cannot be given intramuscularly due to increased risk of hematoma
Note
INNOHEP 10000 IU/ml Solution for Injection manufactured by AIN MEDICARE SDN. BHD . Its generic name is Tinzaparin sodium. INNOHEP is availble in Saudi Arabia.
Farmaco SA drug index information on INNOHEP Solution for Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.